BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexander Reyzelman, MD
Center for Clinical Research Castro Valley- Main site Post Street -Satellite site
Principal Investigator - Alisha Oropallo, MD
Northwell Health
Principal Investigator - Caitlin Hicks, MD
Division of Vascular Surgery and Endovascular Therapy, Johns Hopkins Hospital
Principal Investigator - Edouard Aboian, MD
Yale University School of Medicine- Division of Vascular Surgery, Department of Surgery
Principal Investigator - Igor Laskowski, MD
New York Medical College ("NYMC") and Westchester County Health Care Corporation, operator of Westchester Medical Center.
Principal Investigator - Jeffrey J Siracuse, MD
Boston Medical Center
Principal Investigator - Khanjan Nagarsheth, MD
University of Maryland
Principal Investigator - Mark Wyers, MD
Beth Israel Deaconess Medical Center (Harvard-Boston)
Principal Investigator - Michael Conte, MD
University of California, San Francisco - Division Vascular and Endovascular surgery
Principal Investigator - Moshe Halak, MD
The Sheba Fund for Health Services and Research, Sheba Medical Center at Tel HaShomer
Principal Investigator - Nathalie Moreels, MD
University Hospital Ghent-Thoracale en vasculaire heelkunde
Principal Investigator - Paata Meshveliani, MD
West Georgia Medical Center (Kutaisi Hospital)
Principal Investigator - Shlomo J Baytner, MD
Director of Vascular Surgery, Laniado Hospital, IL
Principal Investigator - Tony Karram, MD
Director Department of Vascular Surgery & Transplantation Rambam Health Care Campus - IL
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rambam Health Care Campus
Haifa, Israel
- Laniado Hospital
Netanya, Israel
- University of San Francisco
San Francisco, California, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2016
- Primary completion
- 31 Jul 2017
- Completion
- 31 Dec 2027
- Last update posted
- 6 Jun 2025
- Registered enrollment
- 40
- Registry id
- NCT02805023
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.